Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127683521 | 12768352 | 1 | I | 20160920 | 20160921 | 20160921 | EXP | JP-FRESENIUS KABI-FK201606785 | FRESENIUS KABI | TESHIGAWARA S,KATADA Y,MAEDA Y,YOSHIMURA M,KUDO-TANAKA E,TSUJI S,ET AL.. HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS WITH LEUKOENCEPHALOPATHY IN A PATIENT WITH DERMATOMYOSITIS ACCOMPANIED WITH PERIPHERAL T-CELL LYMPHOMA: A CASE REPORT. JOURNAL OF MEDICAL CASE REPORTS 2016 AUG 02;NO. 212:1-7. | 17.00 | YR | M | Y | 0.00000 | 20160921 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127683521 | 12768352 | 1 | PS | DEXAMETHASONE INJECTION (manufacturer unknown) | DEXAMETHASONE | 1 | Unknown | D | U | UNKNOWN | 84916 | 20 | MG | UNKNOWN | QD | ||||
| 127683521 | 12768352 | 2 | SS | DEXAMETHASONE INJECTION (manufacturer unknown) | DEXAMETHASONE | 1 | Unknown | D | U | UNKNOWN | 84916 | 20 | MG | UNKNOWN | QD | ||||
| 127683521 | 12768352 | 3 | SS | METHYLPREDNISOLONE (manufacturer unknown) | METHYLPREDNISOLONE | 1 | D | U | UNKNOWN | 40583 | 60 | MG | UNKNOWN | QD | |||||
| 127683521 | 12768352 | 4 | SS | ETOPOSIDE (Manufacturer Unknown) | ETOPOSIDE | 1 | Unknown | D | U | UNKNOWN | 74983 | 120 | MG/KG | UNKNOWN | /wk | ||||
| 127683521 | 12768352 | 5 | SS | CYCLOPHOSPHAMIDE (Manufacturer unknown) | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | D | U | UNKNOWN | 0 | UNKNOWN | |||||||
| 127683521 | 12768352 | 6 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 0 | |||||||||||
| 127683521 | 12768352 | 7 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127683521 | 12768352 | 1 | Central nervous system lesion |
| 127683521 | 12768352 | 3 | Central nervous system lesion |
| 127683521 | 12768352 | 4 | Histiocytosis haematophagic |
| 127683521 | 12768352 | 5 | Central nervous system lesion |
| 127683521 | 12768352 | 6 | Histiocytosis haematophagic |
| 127683521 | 12768352 | 7 | Histiocytosis haematophagic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127683521 | 12768352 | DE |
| 127683521 | 12768352 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127683521 | 12768352 | Peripheral T-cell lymphoma unspecified | |
| 127683521 | 12768352 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |